AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Corporate Update Conference Call SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. plans to webcast a Corporate Update Conference Call on Thursday, December 18, 2003 at 4:30 p.m. Eastern/1:30 p.m. Pacific. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. The Company will provide updates on the SYMLIN(R) (pramlintide acetate) and exenatide (synthetic exendin-4) development programs. The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. A recording will be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at 888-286-8010 (domestic) or 617-801-6888 (international), passcode 70309246. Amylin Pharmaceuticals is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and other metabolic diseases. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright